Synaffix

Feb 18, 2020

Antibody Drug Conjugates (ADCs)-Linker and Conjugation Technologies Market, 2019-2030

Feb 18, 2020

Global ADC Linker & Conjugation Technologies Markets to 2030 - Featuring Executive Insights from Stakeholders in Miracogen, NBE Therapeutics, Synaffix and EUCODIS Bioscience

Nov 06, 2019

Global Antibody Drug Conjugates Market Report 2019-2030

Aug 29, 2019

The Antibody Drug Conjugates Market is Projected to be Worth More Than USD 15 Billion by 2030, Growing at a CAGR of Over 20%, Claims Roots Analysis

Aug 06, 2019

ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial

Oct 02, 2018

ADC Contract Manufacturing Market (3rd Edition), 2018-2030

Nov 30, 2017

Antibody Drug Conjugates Market (4th Edition), 2017-2030

Oct 25, 2017

New Study: 'Double Decker' Antibody Technology Fights Cancer

Sep 18, 2017

101 Antibody-Drug Conjugate Experts to Present at the Industry's Longest Standing & Most Comprehensive Antibody-Drug Conjugate Conference